Test Price
2,800 AED✅ Home Collection Available
LAMB1 Gene Lissencephaly Type 5 Genetic Test in UAE
Executive Summary & Core Metrics
Why UAE Families Trust Our LAMB1 Test
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Next-Generation Sequencing.
- Premium Logistics: VIP Mobile Phlebotomy and Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed genetic counsellors.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This next‑generation sequencing (NGS) test thoroughly analyses the entire coding region of the LAMB1 gene, the definitive biomarker for autosomal recessive cobblestone lissencephaly type 5 (LIS5). Unlike generic gene panels, our single‑gene‑focused assay delivers industry‑leading diagnostic precision with a turnaround of 3–4 weeks, at 2800 AED.
| Feature | Our LAMB1 NGS Test | Closest Alternative (Whole Exome Sequencing) |
|---|---|---|
| Precision | 99.9% sensitivity for LAMB1 variants | Variable; may miss deep intronic mutations |
| Method | Targeted NGS (LAMB1 gene) | Exome‑wide capture + LAMB1 bioinformatic extraction |
| Turnaround | 3–4 weeks | 6–10 weeks |
Physician Insight & Safety Protocols
“As a DHA‑licensed Consultant Medical Genetics, I have witnessed how early molecular confirmation of LAMB1‑related lissencephaly can fundamentally redirect a family’s care plan. Please remember that this DNA test is a powerful tool but must always be correlated with a detailed neurological examination and brain imaging. Your child’s treatment decisions must never be altered based on a genetic result alone.”
— Lina Osama Zaki Quteineh (DHA Registration ID: 9294403)
⚠️ Medication Advisory
Do not discontinue any prescribed anti‑epileptic, hormonal, or neuro‑protective medication without consulting your treating physician.
Patient Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Neonates less than 48 hours old; individuals unable to provide informed consent (legal guardian must sign).
- Exclusion: Patients who have received a whole blood transfusion within the preceding 4 weeks (risk of donor DNA contamination).
- ER Red Flag: If the child develops new‑onset seizures, apneic spells, or sudden loss of consciousness, proceed immediately to the nearest emergency department – do not wait for test results.
- ER Red Flag: Any child in whom a clinical diagnosis of lissencephaly is suspected should already be under the care of a pediatric neurologist; this test is confirmatory, not for acute triage.
Patient FAQ & Clinical Guidance
1. Why does my child need a LAMB1 genetic test if MRI already shows lissencephaly?
Answer: The LAMB1 DNA test pinpoints the exact molecular cause, distinguishing LIS5 from other lissencephaly types and guiding prognosis, recurrence risk, and targeted surveillance for muscle‑eye‑brain involvement.
2. How do you ensure my infant’s sample is not mixed up and privacy remains protected?
Answer: Each sample is barcoded at the point of phlebotomy, processed in an ISO 9001:2015 facility, and handled strictly under UAE PDPL, ensuring end‑to‑end chain‑of‑custody and data encryption.
3. Can I get the test done at home for my child with special needs?
Answer: Yes, our VIP Mobile Phlebotomy service visits your home across all Emirates from 8 AM to 11 PM, using a finger‑prick or venous draw with minimal distress for the child.
UAE Regulatory & Data Privacy Adherence
This test is performed at DNA Labs UAE, a DHA-licensed facility (License No. 1143). All genetic data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | LAMB1 Gene Lissencephaly Type 5 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (venous or finger‑prick) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Targeted gene analysis |
| ICD-10-CM Code | Q04.3 (Lissencephaly) – Use additional code for specific type if documented |
| LOINC Code | 81247-9 (LAMB1 gene targeted mutation analysis) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians